[1]
G. Jugder, O. Unshigbayar, P. Ichinkhorloo, T. Boldoo, and E. Purev, “The Use of Double Test Biomarkers to Predict Fetal Nuchal Translucency Thickness in the Diagnosis of Trisomy 21: A Compromise between Sensitivity and Specificity”, Cent. Asian j. Med. Sci., vol. 4, no. 3, pp. 230–237, Sep. 2018.